Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial — Christian Torp‐Pedersen (2007) | RDL Network
Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial
Article 2007 en
Authors
CT
Christian Torp‐Pedersen
IC
Ian D. Caterson
WC
Walmir Coutinho
Abstract
1 min read
Six-week treatment with sibutramine appears to be efficacious, tolerable and safe in this high-risk population for whom sibutramine is usually contraindicated.
Ian D. Caterson, Walmir Coutinho, Nick Finer, Luc Van Gaal, Aldo Maggioni, Christian Torp‐Pedersen, Arya M. Sharma, Hong Ge, D Santoro, Gillian Shepherd, Philip James
Arya M. Sharma, Ian D. Caterson, Walmir Coutinho, Nick Finer, L. Van Gaal, Aldo Maggioni, Christian Torp‐Pedersen, Hans Peter Bacher, G Shepherd, W. P. T. James
Ian D. Caterson, Nick Finer, Walmir Coutinho, Luc F. Van Gaal, Aldo Maggioni, Christian Torp‐Pedersen, Arya M. Sharma, Udo F. Legler, G Shepherd, Richard A. Rode, Renee Perdok, Cheryl Renz, W. P. T. James
Discussion(0)
No comments yet. Be the first to comment.